The ERK and p38MAPK Pathways as Targets for Anti-Inflammatory Therapy

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 6, Iss. 1, 2007-01 ,pp. : 85-97

Bentham Science Publishers

Access to resources Recommend Favorite

Silymarin augments human cervical cancer HeLa cell apoptosis via P38/JNK MAPK pathways in serum-free medium

By Huang Qing  

Journal of Asian Natural Products Research, Vol. 7, Iss. 5, 2005-10 ,pp. : 701-709

Taylor & Francis Ltd

Access to resources Recommend Favorite

Angiotensin-(1–7) Inhibits Vascular Remodelling in Rat Jugular Vein Grafts via Reduced ERK1/2 and p38 MAPK Activity

By Wu J-G   Tang H   Liu Z-J   Ma Z-F   Tang A-L   Zhang X-J   Gao X-R   Ma H  

The Journal of International Medical Research, Vol. 39, Iss. 6, 2011-11 ,pp. : 2158-2168

Field House Publishing

Access to resources Recommend Favorite

7-prenyloxi-6-methoxycoumarin from Polygala sabulosa A.W. Bennett Regulates p38 MAPK and NF-kB Pathways Inhibiting the Inflammation Induced by Carrageenan in the Mouse Model of Pleurisy

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 14, Iss. 1, 2015-02 ,pp. : 37-46

Bentham Science Publishers

Access to resources Recommend Favorite

PTK, ERK and p38 MAPK contribute to impaired NMDA-induced vasodilation after brain injury

By Armstead W.M.  

European Journal of Pharmacology, Vol. 474, Iss. 2, 2003-08 ,pp. : 249-254

Elsevier

Access to resources Recommend Favorite